EU regulator ‘convinced’ AstraZeneca jab benefits outweigh risks Published on Share
The EU’s medicines regulator said Tuesday it was “firmly convinced” the benefits of AstraZeneca’s vaccine outweigh potential risks, insisting there was no evidence linking it to blood clots after several nations suspended the shot over health fears.
The suspensions have provoked intense debate over whether it was prudent to put AstraZeneca inoculations on hold just as vaccination campaigns were beginning to gather pace in many countries.
Experts at both the World Health Organization and the European Medicines Agency met Tuesday to discuss the vaccine, with the European organisation expected to publish conclusions Thursday.
Channels Television
Updated March 17, 2021
In this file photo taken on March 09, 2021 a medical worker holds a syringe and a vial of the British-Swedish AstraZeneca/Oxford vaccine during a vaccination campaign at the National Museum of Science and Technology Leonardo Da Vinci. Miguel MEDINA / AFP
Why have several countries in Europe suspended use of the AstraZeneca vaccine, citing fears of blood clots, even as the European Union’s top regulator insists there is no evidence of a link and calls for the inoculations to continue?
Germany, Italy, France and at several other nations say they need time to determine whether the vaccine is in any way responsible for very rare incidents of unusual blood events.
Why Some Countries Have Suspended The Use Of AstraZeneca Vaccine? ndtv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ndtv.com Daily Mail and Mail on Sunday newspapers.
Does the Astrazeneca Covid vaccine cause blood clots?
17 Mar 2021, 10:00
Updated: 17 Mar 2021, 15:15
THE ASTRAZENECA Covid vaccine has been proven safe and effective.
But several countries have suspended its use in the past week over fatal blood clot fears. Read our coronavirus live blog for the latest news & updates.
2
The AstraZeneca vaccine (pictured) is being investigated after fatal blood clots in those jabbedCredit: AFP or licensors
At least 20 European countries have halted use of the AstraZeneca (AZ) vaccine, developed by the University of Oxford, as well as Thailand and the Congo.
EU health officials are investigating a spate of cases of blood clotting in people who have recently had the jab, including a handful of deaths.
EU regulator convinced AstraZeneca jab benefits outweigh risks tuoitrenews.vn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tuoitrenews.vn Daily Mail and Mail on Sunday newspapers.